DAAs in pregnancy are the only potential intervention to decrease vertical transmission: Pregnancy DAA data support safety. [PDF]
Hepatol CommunChappell C, Biondi MJ, Kushner T.
europepmc +1 more source
Integrative multiomics dissection of LSM7 as a prognostic biomarker and therapeutic target in hepatocellular carcinoma. [PDF]
Sci ProgFan S +7 more
europepmc +1 more source
Necrolytic acral erythema in an incarcerated population: A case series. [PDF]
JAAD Case RepAli I, Cavanagh M, Kelly BC.
europepmc +1 more source
Impact of hepatitis C therapy on urinary outcomes and renal function: a prospective real-world cohort study of early kidney changes. [PDF]
BMC NephrolKaartinen K +4 more
europepmc +1 more source
2025 KASL clinical practice guidelines for management of hepatitis C. [PDF]
Clin Mol HepatolJang ES +11 more
europepmc +1 more source
Trends in Use of Direct-Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016-2024. [PDF]
J Viral HepatLuong CL +4 more
europepmc +1 more source
Real-world Effectiveness and Safety of Coblopasvir plus Sofosbuvir in the Treatment of Chronic Hepatitis C Infection in Wenzhou, Eastern China: A Multicenter Observational Study. [PDF]
J Clin Transl HepatolRuan LM +8 more
europepmc +1 more source
[Recent Advances in the Treatment of Chronic Hepatitis C]. [PDF]
Korean J GastroenterolKim SB.
europepmc +1 more source
Efficacy of Sofosbuvir-Velpatasvir-Ribavirin Regimen for Retreatment of Chronic Hepatitis C in Patients With Prior DAA Failure: A Retrospective Study From a National Treatment Center. [PDF]
Int J HepatolSingh S +6 more
europepmc +1 more source
Influence of antiviral treatment in hepatitis C patients on metabolism and fibrosis process. [PDF]
Front Med (Lausanne)Jędrysik M +4 more
europepmc +1 more source